MUSECELL INNOVATIONS Trademark

Analysis of stem cells for medical research; cell culture services for scientific and research purposes, for others; culturing of cells for others for scientific research purposes; research and development in the field of microorganisms and cells; research and development services in the field of microorganisms and cells; research in the field of cell engineering technology; research of induced pluripotent stem cells; scientific laboratory and research services relating to the isolation and cultivation of human tissues and cells; stem cell medical research services; stem cell research services.

Anti-aging cosmetic preparations; anti-aging cream; anti-aging creams; anti-aging creams for cosmetic purposes; anti-aging creams for sun protection for the face and body; anti-aging masks for cosmetic purposes; anti-aging moisturisers; anti-aging moisturizers; anti-aging serums for cosmetic purposes; Non-medicated anti-aging serums for cosmetic use; Non-medicated anti-aging serums for sensitive skin; Non-medicated anti-aging skincare preparations, namely, creams, lotions, gels, toners, cleaners and peels; anti-aging sun protection creams for the face and body.

Human cell bank services, namely, human stem cell storage services; medical services relating to the removal, treatment and processing of stem cells; stem cell bank services; stem cell therapy services; medical services relating to the removal, treatment and processing of human cells; storage of human cells, namely, human tissue bank services; storage of stem cells, namely, stem cell bank services; providing on-line information relating to the prevention of cardiovascular disease and strokes; medical services relating to the removal, treatment and processing of bone marrow; medical services relating to the removal, treatment and processing of umbilical cord blood; providing information relating to the treatment of cardiovascular and cerebrovascular diseases via the internet; health care services for treating Alzheimer's disease.

Cells for medical purposes; cells for medical use; cellular function activating agents for medical purposes; cellulose esters for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes; chemical reagents and chemical preparations for cell separation and cultivation for medical or veterinary purposes; chemical reagents and chemical preparations for separating and cultivating cells for medical or veterinary purposes; living cells for medical purposes; living cells for medical use; pharmaceutical compositions containing stem cells for the treatment of antibody-treatable, autoimmune, inflammatory, oncological, neurologic, cardiovascular, orthopedic, infectious, gastrointestinal, and genetic diseases; pharmaceutical preparations containing stem cells for antibody-treatable, autoimmune, inflammatory, oncological, neurologic, cardiovascular, orthopedic, infectious, gastrointestinal, and genetic diseases and conditions and for treatment of cellular aging; pharmaceutical preparations for activating cellular function; stem cells for medical purposes; autoinjectors prefilled with pharmaceutical preparations for antibody-treatable, autoimmune, inflammatory, oncological, neurologic, cardiovascular, orthopedic, infectious, gastrointestinal, and genetic diseases and conditions and for treatment of cellular aging; immunological products, namely, pharmaceutical preparations, for intravenous injections for antibody-treatable, autoimmune, inflammatory, oncological, neurologic, cardiovascular, orthopedic, infectious, gastrointestinal, and genetic diseases and conditions and for treatment of cellular aging; injectable medicinal solutions, namely, pharmaceutical preparations, for antibody-treatable, autoimmune, inflammatory, oncological, neurologic, cardiovascular, orthopedic, infectious, gastrointestinal, and genetic diseases and conditions and for treatment of cellular aging; injectable solutions, namely, pharmaceutical preparations, for medical purposes for antibody-treatable, autoimmune, inflammatory, oncological, neurologic, cardiovascular, orthopedic, infectious, gastrointestinal, and genetic diseases and conditions and for treatment of cellular aging; injectable solutions, namely, pharmaceutical preparations, for use in inhibiting peristalsis for medical purposes; pharmaceutical preparations sold in pre-filled injectors for antibody-treatable, autoimmune, inflammatory, oncological, neurologic, cardiovascular, orthopedic, infectious, gastrointestinal, and genetic diseases and conditions and for treatment of cellular aging; intravenous fluids used for the delivery of pharmaceutical preparations; intravenous solutions for medical purposes used for rehydration, nutrition and the delivery of pharmaceutical preparations; immunosuppressive pharmaceutical preparations; pharmaceutical preparations for the treatment of cystic fibrosis; glycerophosphates for antibody-treatable, autoimmune, inflammatory, oncological, neurologic, cardiovascular, orthopedic, infectious, gastrointestinal, and genetic diseases and conditions and for treatment of cellular aging; pharmaceutical preparations containing phosphates for antibody-treatable, autoimmune, inflammatory, oncological, neurologic, cardiovascular, orthopedic, infectious, gastrointestinal, and genetic diseases and conditions and for treatment of cellular aging; cardiovascular agents for medical purposes; cardiovascular pharmaceutical preparations; cardiovascular pharmaceuticals; cardiovascular preparations; cardiovascular treatment preparations; drugs, namely, pharmaceutical preparations for the treatment of cardiovascular diseases; medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations and substances for the prevention of cardiovascular diseases and disorders; pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the prevention of cardiovascular disorders; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of cardiovascular disorders; pharmaceutical preparations for treating cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of kidney diseases; anti-ulcer agents; pharmaceutical preparations being antiulceratives; pharmaceutical preparations for the treatment of chronic liver diseases.